TY - JOUR
T1 - When phenotype does not match genotype
T2 - importance of “real-time” refining of phenotypic information for exome data interpretation
AU - Basel-Salmon, Lina
AU - Ruhrman-Shahar, Noa
AU - Orenstein, Naama
AU - Goldberg, Yael
AU - Gonzaga-Jauregui, Claudia
AU - Shuldiner, Alan R.
AU - Sukenik-Halevy, Rivka
AU - Maya, Idit
AU - Magal, Nurit
AU - Hagari, Ofir
AU - Azulay, Noy
AU - Lidzbarsky, Gabriel Arie
AU - Bazak, Lily
N1 - Publisher Copyright:
© 2020, American College of Medical Genetics and Genomics.
PY - 2021/1
Y1 - 2021/1
N2 - Purpose: Clinical data provided to genetic testing laboratories are frequently scarce. Our purpose was to evaluate clinical scenarios where phenotypic refinement in proband’s family members might impact exome data interpretation. Methods: Of 614 exomes, 209 were diagnostic and included in this study. Phenotypic information was gathered by the variant interpretation team from genetic counseling letters and images. If a discrepancy between reported clinical findings and presumably disease-causing variant segregation was observed, referring clinicians were contacted for phenotypic clarification. Results: In 16/209 (7.7%) cases, phenotypic refinement was important due to (1) lack of cosegregation of disease-causing variant with the reported phenotype; (2) identification of different disorders with overlapping symptoms in the same family; (3) similar features in proband and family members, but molecular cause identified in proband only; and (4) previously unrecognized maternal condition causative of child’s phenotype. As a result of phenotypic clarification, in 12/16 (75%) cases definition of affected versus unaffected status in one of the family members has changed, and in one case variant classification has changed. Conclusion: Detailed description of phenotypes in family members including differences in clinical presentations, even if subtle, are important in exome interpretation and should be communicated to the variant interpretation team.
AB - Purpose: Clinical data provided to genetic testing laboratories are frequently scarce. Our purpose was to evaluate clinical scenarios where phenotypic refinement in proband’s family members might impact exome data interpretation. Methods: Of 614 exomes, 209 were diagnostic and included in this study. Phenotypic information was gathered by the variant interpretation team from genetic counseling letters and images. If a discrepancy between reported clinical findings and presumably disease-causing variant segregation was observed, referring clinicians were contacted for phenotypic clarification. Results: In 16/209 (7.7%) cases, phenotypic refinement was important due to (1) lack of cosegregation of disease-causing variant with the reported phenotype; (2) identification of different disorders with overlapping symptoms in the same family; (3) similar features in proband and family members, but molecular cause identified in proband only; and (4) previously unrecognized maternal condition causative of child’s phenotype. As a result of phenotypic clarification, in 12/16 (75%) cases definition of affected versus unaffected status in one of the family members has changed, and in one case variant classification has changed. Conclusion: Detailed description of phenotypes in family members including differences in clinical presentations, even if subtle, are important in exome interpretation and should be communicated to the variant interpretation team.
KW - exome
KW - overlapping features
KW - phenotypic information
KW - variant classification
KW - variant interpretation
UR - http://www.scopus.com/inward/record.url?scp=85089452740&partnerID=8YFLogxK
U2 - 10.1038/s41436-020-00938-5
DO - 10.1038/s41436-020-00938-5
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 32801363
AN - SCOPUS:85089452740
SN - 1098-3600
VL - 23
SP - 215
EP - 221
JO - Genetics in Medicine
JF - Genetics in Medicine
IS - 1
ER -